NASDAQ:SEEL
Seelos Therapeutics Inc. Stock News
$0.91
-0.0531 (-5.53%)
At Close: Jun 14, 2024
Why Novartis, Seelos Therapeutics And More Are Moving Today
11:52am, Tuesday, 26'th Jan 2021
Allogene Therapeutics (NASDAQ: ALLO) shares are trading higher Tuesday after Stifel upgraded the stock from Hold to Buy and raised its price target from $33 to $43 per share. Allogene is a U.S.-based
Why Fluidigm, Seelos Therapeutics And More Are Moving Today
11:27am, Friday, 22'nd Jan 2021
Fluidigm (NASDAQ: FLDM) shares are trading higher Friday after the company announced it received the CE-IVD mark for its Advanta Dx SARS-CoV-2 RT-PCR Assay. Fluidigm manufactures life science tools fo
NEW YORK, Jan. 15, 2021 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorder
Seelos Therapeutics to Participate in the 3rd International Conference on Sanfilippo Syndrome and Related Diseases
09:24am, Monday, 09'th Nov 2020
NEW YORK, Nov. 9, 2020 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders
